Latest 10-K annual reports

Johnson & Johnson reported robust financial performance in fiscal year 2025 with 6.0% sales growth and a significant increase in earnings before taxes, while advancing its strategic plan to separate its Orthopaedics business.

Kemper Corporation's net income and adjusted operating income saw a substantial decrease in 2025, primarily driven by deteriorating underwriting results in its Specialty Property & Casualty segment and increased prior year reserve development.

Neurocrine Biosciences achieved significant revenue growth in 2025 driven by strong INGREZZA sales and the successful launch of CRENESSITY, while advancing a robust pipeline and navigating evolving regulatory landscapes.

Hexcel Corporation's 2025 annual report reveals a slight dip in net sales to $1.89 billion, driven by commercial aerospace softness, offset by growth in defense and space, alongside strategic divestitures and a new $600 million share repurchase plan.

NVR, Inc. reported a significant decline in 2025 net income and diluted earnings per share, alongside decreased revenues and new orders, attributing the downturn to affordability issues and economic volatility.

Textron Inc. reported an 8% revenue increase and 14% segment profit growth in 2025, driven by strong performance in its aviation and defense segments, alongside key leadership changes and strategic business realignments.

BorgWarner reports a 2% net sales increase to $14.3 billion in 2025, driven by eProducts growth and foreign currency, but net earnings declined due to significant impairment charges and restructuring costs.

Black Hills Corporation reported increased net income and gas utility operating income in 2025, alongside a decrease in electric utility operating income, as it progresses towards a significant merger with NorthWestern Energy.

Acro Biomedical Co., Ltd. reports no revenue since late 2022, significant losses, and a going concern warning, alongside a recent CEO change and challenges in its cordyceps product market.

Stryker Corporation achieved robust net sales and adjusted earnings growth in 2025, driven by strategic acquisitions and innovative product launches across its MedSurg, Neurotechnology, and Orthopaedics segments.

Bristol-Myers Squibb reports flat 2025 revenues, with strong growth in its new portfolio offsetting declines from generic competition and increased government rebates.

Mastercard announced robust financial and operational performance in 2025, driven by growth in its payment network and value-added services, alongside significant capital returns to shareholders.

Hilton Worldwide Holdings Inc. reported a slight dip in net income for 2025 despite revenue growth and significant global expansion, alongside substantial share repurchases.

Royalty Pharma reports robust 16.2% growth in Portfolio Receipts to $3.3 billion in 2025, driven by strategic acquisitions and product performance, despite a dip in net income attributable to shareholders.

NNN REIT, a leading triple-net lease REIT, expanded its property portfolio and increased its annual dividend for the 36th consecutive year, despite a decline in net earnings and higher operating expenses in 2025.

Nuvectis Pharma's latest 10-K filing highlights positive Phase 1a results for its lead oncology drug candidate NXP900, while reporting continued significant operating losses and the cessation of NXP800 clinical development.

Avantor, Inc. reported a net loss of $530.2 million for fiscal year 2025, primarily driven by a significant goodwill impairment charge and declining net sales, despite a debt refinancing and cost transformation efforts.

Centrus Energy Corp. reports strong financial performance in 2025, driven by HALEU production and significant expansion plans for domestic uranium enrichment, despite geopolitical supply chain risks.

Fannie Mae's 2025 net income decreased to $14.4 billion, primarily due to a shift from credit loss benefits to provisions, despite an increase in net worth.

Shopify Inc. announced a 30% revenue increase to $11.6 billion in 2025, driven by merchant solutions, despite a 39% drop in net income due to investment losses.

Unity Software Inc. reported a significant reduction in net losses and increased revenue for the fiscal year ended December 31, 2025, driven by growth in its Grow Solutions and a strategic portfolio reset.

Urban Edge Properties LP reported a significant increase in net income and strong leasing activity for 2025, alongside strategic debt refinancing and active redevelopment projects.

Blackstone Mortgage Trust reported a net income of $109.6 million for 2025, a significant improvement from the prior year's loss, despite a decrease in distributable earnings and an increase in leverage, while also amending key financing agreements to extend maturities and adjust covenants.

NiSource Inc. reports increased net income and significant infrastructure investments in 2025, driven by successful regulatory outcomes and strategic expansion into data center services.

Parsons Corporation reported a 5.7% revenue decline in 2025, primarily due to a significant drop in its Federal Solutions segment, despite an increase in net income and strong growth in Critical Infrastructure.

Zillow Group achieved significant revenue growth and returned to GAAP profitability in 2025, driven by strong performance in its Rentals and Mortgages segments and strategic product innovations.

Diodes Incorporated reported a 13% increase in net sales for 2025, reaching $1.5 billion, fueled by robust demand in AI server-related computing, automotive, and industrial markets.

Legato Merger Corp. III filed its annual 10-K report for fiscal year 2025, detailing financial results and confirming a business combination agreement with Einride AB expected to close in Q1 2026.

NETSTREIT Corp. achieved significant portfolio growth and increased net income in 2025, driven by strategic acquisitions and debt financing, despite rising interest expenses.

A. O. Smith Corporation reports a slight sales increase in 2025 driven by North America and acquisitions, while facing continued weak demand in China and strategic assessment of its China business.